Emil Kumar

5PUBLICATIONS

24CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Comparative language studiesMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Jul 03, 2026

Response-adapted chimeric antigen receptor T cell (CAR-T)-sparing consolidation radiotherapy in high-risk large B-cell lymphoma (LBCL): Results of the prospective RESTART protocol.

|Mar 27, 2026

Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.

Andrea Kuhnl, Amy A Kirkwood, Michael Northend

|Sep 12, 2025

MTV-guided radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T-cell therapy.

Andrea Kuhnl, S Bouziana, S F Barrington

|Jan 17, 2025

CAR T access and outcomes in large B-cell lymphoma according to ethnicity and socioeconomic deprivation in the UK.

Diana Dragoi, Samuel Cusworth, Laura Oldham

|Aug 27, 2024

CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma.

Emil Arjun Kumar, Koorosh Korfi, Findlay Bewicke-Copley

Pageof 1

Frequent Collaborators

Robin Sanderson

Andrea Kuhnl

M Northend

S F Barrington

T Menne

R Johnson

R Benjamin

R Prestwich

N G Mikhaeel

Frances Seymour

Frequent Collaborators

Robin Sanderson

Andrea Kuhnl

M Northend

S F Barrington